The 5% Trap: Why Hospital Women's Health Expansions Are Failing to Drive Revenue
51% of provider organizations admit their specialized maternal and gynecological expansions contribute less than 5% to downstream revenue.
Boston MA -- October 6: Health systems are successfully building the front door to women's healthcare, but they are completely failing to capture the lifetime value of those patients.
The Women's Health Infrastructure Report 2026 reveals that despite growing investment and strategic focus, many hospitals remain in the early stages of realizing the true commercial potential of female-focused care.
While access expansion and service line growth are universally ranked as key priorities, a glaring growth illusion persists[cite: 13]. By treating pregnancy as a discrete, isolated event rather than a window into a woman's lifelong health trajectory, systems are losing patients to fragmented outpatient providers the moment the pregnancy episode ends.
This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.
The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.
Women’s HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.